Schedule 13G ownership disclosure
Amicus Therapeutics Inc
Security class unavailable · CUSIP: 03152W109
Event date: 2014-06-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 7,356,906
- Percent of class
- 9.3500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001425738-14-000006
- Form type
- SC 13G
- Filer
- AMICUS THERAPEUTICS, INC.
- CIK
- CIK 1178879
- Filed
- Oct 09, 2014
- Reporting period
- Jun 30, 2014
- Description
- Schedule 13G beneficial ownership